Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer

Dan Med Bull. 2006 May;53(2):172-209.
No abstract available

Publication types

  • Review

MeSH terms

  • Adipokines
  • Animals
  • Antirheumatic Agents / pharmacology
  • Antirheumatic Agents / therapeutic use
  • Apoptosis / physiology
  • Arthritis, Rheumatoid / blood
  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / pathology
  • Arthritis, Rheumatoid / physiopathology
  • Biomarkers / metabolism*
  • Biomarkers, Tumor / blood
  • Breast Neoplasms / blood
  • Breast Neoplasms / mortality
  • Chitinase-3-Like Protein 1
  • Chondrocytes / metabolism
  • Communicable Diseases / blood
  • Communicable Diseases / genetics
  • Communicable Diseases / physiopathology*
  • Disease Progression
  • Extracellular Matrix / metabolism
  • Fibrosis
  • Glycoproteins / blood
  • Glycoproteins / genetics
  • Glycoproteins / metabolism
  • Glycoproteins / physiology*
  • Humans
  • Immunohistochemistry
  • Inflammation / blood
  • Inflammation / genetics
  • Inflammation / physiopathology*
  • Inflammatory Bowel Diseases / blood
  • Inflammatory Bowel Diseases / physiopathology
  • Lectins
  • Liver / metabolism
  • Liver Cirrhosis / blood
  • Liver Cirrhosis / diagnosis
  • Lung / pathology
  • Macrophages / physiology
  • Neoplasms / blood
  • Neoplasms / physiopathology*
  • Osteoarthritis / blood
  • Prognosis
  • Sarcoidosis / blood
  • Sarcoidosis / pathology
  • Spondylitis, Ankylosing / blood
  • Synovial Fluid / chemistry
  • Synovial Membrane / pathology

Substances

  • Adipokines
  • Antirheumatic Agents
  • Biomarkers
  • Biomarkers, Tumor
  • CHI3L1 protein, human
  • Chitinase-3-Like Protein 1
  • Glycoproteins
  • Lectins